<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Office of President &amp; Vice-Chancellor</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/85C71D88-B807-463D-A3B9-405F82E74D39"><gtr:id>85C71D88-B807-463D-A3B9-405F82E74D39</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Pickering-Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400356"><gtr:id>78E7E78F-7139-43BD-A8A5-3C0C8D12DF3A</gtr:id><gtr:title>Furthering the genetics of frontotemporal dementia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400356</gtr:grantReference><gtr:abstractText>The proportion of elderly people in our society is increasing. As a result there is an increase in the number of people with age related degenerative diseases that cause dementia. It is known that dementia, in certain circumstances, can be inherited and run in families. Approximately 750,000 people in the UK have some form of dementia, the most common and widely known is Alzheimer?s disease. Thankfully, a lot of progress has been made in understanding the genetic cause of Alzheimer?s disease. The second most common form of dementia is called frontotemporal dementia or FTD. It can affect people?s behaviour and ability to speak. About half of all people with FTD have other family members with this disease, therefore, there is a large inherited (genetic) reason for the development of this disease. We know around 10% of cases of FTD are caused by errors in a gene called tau, however, we know nothing about the remaining 90%. There are reports of families with FTD showing there is a gene problem on chromosome 17, where the tau gene lies. However, nobody has been able to find any errors in the tau gene in these families. I will analyse the entire tau gene, more thoroughly than has been done before, and will check nearby genes to identify the disease causing error. The second part of my project is as follows; By testing a large collection of FTD patients collected from around Manchester I have shown there is a gene causing FTD with motor neuron disease on chromosome 9, consistent with a report from the US. By identifying common regions of chromosome 9 shared by patients from Manchester, and screening the genes within these regions, I hope to identify the disease-causing gene. Finally, it has been reported that errors in a gene called VCP can cause a bone disease and FTD in some patients. I will screen the Manchester FTD patients to see if VCP is causing disease in any of them. In summary, it is important to find genes causing FTD because it is a common form of dementia with a large genetic component to its cause. By identifying these genes we will find the primary cause of, and gain understanding to, the biological problem reason of disease. This knowledge will help in diagnosis and in the development of systems to produce a treatment, which will ultimately help people affected by this illness.</gtr:abstractText><gtr:technicalSummary>Neurodegenerative diseases of our progressively more aged society are becoming an increasing social and economic burden. Frontotemporal dementia (FTD) is now recognised as a major cause of dementia, being the second most common cause in people under 65 years. FTD accounts for approximately 20% of early onset dementia. Importantly, 40-50% of patients have a family history of this disease, therefore, there is a major genetic contribution to FTD aetiology. Mutations in the tau gene on chr17 account for around 10% of cases, but the genetic cause of the majority of FTD remains unknown. I propose to further knowledge of the genetic cause of FTD in 3 specific areas by testing the hypothesis that causative genes for this disease are located on chr9 and 17q. Firstly, there are reports of FTD families linked to chr17q in which mutations in the tau gene appear absent, I have recently identified one such family of English decent (2 point LOD score 2.7, multipoint LOD 3.3). Consistent with other such families no obvious exonic or splicing mutations are present in tau and a tau-based neuropathology is absent. To identify the disease gene I propose to sequence the whole tau locus using the MRC Geneservice facility. Estimates from Geneservice for this is 10-14 weeks. If no mutations are detected I will sequence all other genes within the 5.3Mb linkage region. Secondly, linkage to chr9q has been reported in families with FTD and motor neuron disease (MND). I have similarly demonstrated linkage to chr9q in 5 small families with FTD+MND (combined 2 point LOD 2.9, multipoint LOD 3.45). Moreover, separately I have also demonstrated association between d9s1122 (p=0.043) and disease in the Manchester FTD cohort and inferred haplotype analysis indicates the presence of 2 chr9q-linked families. I propose to further this analysis, incorporating newly ascertained cases (n=70), using linkage disequilibrium mapping to refine associated haplotypes for causative and/or susceptibility gene identification. Finally, it has been established the VCP gene on chr9p causes Paget?s disease with inclusion body Myopathy and FTD. I will screen the Manchester FTD cohort (n=272) ascertaining the extent VCP mutations are responsible for prototypical FTD. My long-term aim of furthering knowledge in the genetics of FTD will contribute to accurate diagnosis and will illuminate the biological dysfunction underlying this and possibly other neurodegenerative diseases. This will facilitate production of disease model systems that will hopefully be of use in the generation of therapeutics.</gtr:technicalSummary><gtr:fund><gtr:end>2008-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>324090</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mayo</gtr:description><gtr:id>C20F90E0-4609-494B-A834-EF40551A890F</gtr:id><gtr:impact>Numerous high impact papers in Nature and Brain 18192287, 17826340, 17071927, 17071926, 17030535, 17003069, 16950801, 16862116, 16401619</gtr:impact><gtr:outcomeId>004619AB8C9-1</gtr:outcomeId><gtr:partnerContribution>exchange of DNA</gtr:partnerContribution><gtr:piContribution>We helped in the identification of mutations in progranulin being a common cause of frontotemporal dementia</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC Radio Manchester interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D2C9A7C9-B5A5-4DFD-A083-CB5E4838E4A9</gtr:id><gtr:impact>I was interviewed on the Sam Walker show about my work on frontotemporal dementia and how the patients from Manchester have helped with this

I hope the people of Manchester now realise how much they have added research</gtr:impact><gtr:outcomeId>6E2E2833AA9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>presentation to A level students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3346AAD8-6773-4D48-89A8-082B3DF38189</gtr:id><gtr:impact>presentation to A level students at Manchester Museum to describe what doing actual biomedical research is like

the students got to see what actual research is about</gtr:impact><gtr:outcomeId>2518D100B97</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>64000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC New Investigator Grant (supplement)</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D9B070F4-BDB2-4CE2-9656-543F7D4F9031</gtr:id><gtr:outcomeId>7660DA557480</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Non-Clinical Research Fellowship</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>671B8901-9181-476B-8059-42F3A86157A2</gtr:id><gtr:outcomeId>8E3C5590EAA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Protects using UBAP1 to treat frontotemporal dementia</gtr:description><gtr:grantRef>G0400356</gtr:grantRef><gtr:id>E32D162F-B01D-4C7B-A71B-F76C5066248D</gtr:id><gtr:impact>none</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>4E4BAF9D8E9</gtr:outcomeId><gtr:patentId>WO2009037481</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Patent on UBAP1</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>this protects IP relating to diagnosing frontotemporal dementia with genetic testing and treatment with progranulin</gtr:description><gtr:grantRef>G0400356</gtr:grantRef><gtr:id>65F0A34C-497A-4E11-A9E1-9E57FD2C672E</gtr:id><gtr:impact>none</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>8388D2B91E5</gtr:outcomeId><gtr:patentId>US2010105034</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Patent on progranulin mutations</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Progranulin</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>897FBFC0-77A2-404F-A2F6-4800ACC013A6</gtr:id><gtr:outcomeId>8C0788ED628</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6E15EABE-59A8-45C0-AE41-65A983C92EC2</gtr:id><gtr:title>The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/515bfdcc03f3aef9a0610ccbd57d67f5"><gtr:id>515bfdcc03f3aef9a0610ccbd57d67f5</gtr:id><gtr:otherNames>Mackenzie IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>AD74BDB4700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5367B87-4FA3-4E36-A349-5805DDB8A9BC</gtr:id><gtr:title>Progranulin and frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9794ad281d069953d2256a1d9ad44d4"><gtr:id>f9794ad281d069953d2256a1d9ad44d4</gtr:id><gtr:otherNames>Pickering-Brown SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>6239E6CC08C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02401AA7-F9B8-4195-AAD9-1693B919EC6D</gtr:id><gtr:title>Familial early-onset dementia with tau intron 10 + 16 mutation with clinical features similar to those of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bcda257b2b6506ba04dddea41424a7d"><gtr:id>1bcda257b2b6506ba04dddea41424a7d</gtr:id><gtr:otherNames>Doran M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>5F8BEA73C22</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0BA75D0-3136-4041-B39B-03506AA6C081</gtr:id><gtr:title>A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/515bfdcc03f3aef9a0610ccbd57d67f5"><gtr:id>515bfdcc03f3aef9a0610ccbd57d67f5</gtr:id><gtr:otherNames>Mackenzie IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>65345D3CA9D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CD19C07-6C63-40EA-9A4F-9A19E7E34C33</gtr:id><gtr:title>Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3d6a66a773a08f7552336ccdc96d730"><gtr:id>a3d6a66a773a08f7552336ccdc96d730</gtr:id><gtr:otherNames>Zhang YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>11DFD996FA0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46B4AFDC-EC4F-4E38-8A5F-99E3669D77DE</gtr:id><gtr:title>Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>95A24371394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEEEF77C-5902-4ED4-B447-F1F0D5DDF445</gtr:id><gtr:title>Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>B2E27CB5DF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF38C24F-10B7-4DF3-8B68-4B6F3D438127</gtr:id><gtr:title>Frontotemporal dementia and parkinsonism associated with the IVS1+1G-&amp;gt;A mutation in progranulin: a clinicopathologic study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a294a4b78f00e1f30d12b591958f819c"><gtr:id>a294a4b78f00e1f30d12b591958f819c</gtr:id><gtr:otherNames>Boeve BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>F67089397D3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44B7B1F3-A068-4C91-A4ED-06ECA3E7027D</gtr:id><gtr:title>The genetics of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/325aae1c7df24cb481f015f7f7136ace"><gtr:id>325aae1c7df24cb481f015f7f7136ace</gtr:id><gtr:otherNames>Sikkink S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>08D1D8794CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93553517-3444-44A0-BC51-AC22E772C0D5</gtr:id><gtr:title>Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e52b4cdd972e44be01530389310c183"><gtr:id>5e52b4cdd972e44be01530389310c183</gtr:id><gtr:otherNames>Wszolek ZK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>A604BBC165B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0E5D7BC-9650-4A37-B2DD-C90E0F482517</gtr:id><gtr:title>Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>3B6FD44E5DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C67394-E786-43A7-B728-37ED45588AE0</gtr:id><gtr:title>Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/549cbf805ce7d8520d8a40810c6b0188"><gtr:id>549cbf805ce7d8520d8a40810c6b0188</gtr:id><gtr:otherNames>Baker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>B7938B1C787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21D5C734-5938-41C0-9CF4-0E53FCC147B8</gtr:id><gtr:title>Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9794ad281d069953d2256a1d9ad44d4"><gtr:id>f9794ad281d069953d2256a1d9ad44d4</gtr:id><gtr:otherNames>Pickering-Brown SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>A0787F35B12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A4E9B8D-B8FA-4202-9813-CB82873E3189</gtr:id><gtr:title>Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83e57575be4e049931208ea594a82fb1"><gtr:id>83e57575be4e049931208ea594a82fb1</gtr:id><gtr:otherNames>Momeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>ACC9D47BDB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BD48092-0AED-49AB-9225-74960036F5D1</gtr:id><gtr:title>Prominent phenotypic variability associated with mutations in Progranulin.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f7fda1848c9b9033c318769a6d491f2"><gtr:id>6f7fda1848c9b9033c318769a6d491f2</gtr:id><gtr:otherNames>Kelley BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>1DD26AA9C3B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5702F205-9B9C-4D8E-AA66-34C8EA7FDD54</gtr:id><gtr:title>Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ac80b42e880cbd4857157a6fb016d"><gtr:id>dd1ac80b42e880cbd4857157a6fb016d</gtr:id><gtr:otherNames>Davidson Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>C96980B6394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D3C9652-3EEB-47F7-AA13-31105DA32595</gtr:id><gtr:title>The complex aetiology of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9794ad281d069953d2256a1d9ad44d4"><gtr:id>f9794ad281d069953d2256a1d9ad44d4</gtr:id><gtr:otherNames>Pickering-Brown SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>9E3712E3F2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE00B88-1EFF-4204-A637-4BF60174AF28</gtr:id><gtr:title>Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ac80b42e880cbd4857157a6fb016d"><gtr:id>dd1ac80b42e880cbd4857157a6fb016d</gtr:id><gtr:otherNames>Davidson Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>EC0A6BC04C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52C5C1D4-F7FF-4649-9166-F76A0097BC14</gtr:id><gtr:title>Mutations in progranulin explain atypical phenotypes with variants in MAPT.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9794ad281d069953d2256a1d9ad44d4"><gtr:id>f9794ad281d069953d2256a1d9ad44d4</gtr:id><gtr:otherNames>Pickering-Brown SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>B5B43670E4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AFBADC8-54DF-48D3-B3F8-A99B4420F493</gtr:id><gtr:title>Progressive anomia revisited: focal degeneration associated with progranulin gene mutation.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>1B3244AF12D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B187581F-4340-4D5F-9411-386B24BBAA6A</gtr:id><gtr:title>TDP-43 gene analysis in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>37FECA4098E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE20663-F451-425E-B348-DCA66F93DEAC</gtr:id><gtr:title>Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/515bfdcc03f3aef9a0610ccbd57d67f5"><gtr:id>515bfdcc03f3aef9a0610ccbd57d67f5</gtr:id><gtr:otherNames>Mackenzie IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>ADB21ECABBF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051478D6-13CE-4695-83CB-D07E95B74C62</gtr:id><gtr:title>Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C--&amp;gt;T (Arg493X) mutation: an international initiative.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfa45f01eb1547ba36c103695b43f0f7"><gtr:id>bfa45f01eb1547ba36c103695b43f0f7</gtr:id><gtr:otherNames>Rademakers R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>1E16D25BBC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>526AD515-A168-4FC5-9118-C29CA6626557</gtr:id><gtr:title>Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869282b1b6804b1c79fb6cf459c4019a"><gtr:id>869282b1b6804b1c79fb6cf459c4019a</gtr:id><gtr:otherNames>Shiarli AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>A0C6EAECA09</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FEB8306-85D0-4DBE-879D-2A176A972DFD</gtr:id><gtr:title>Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e92b788d7864b365f8d8bb27f411e9b7"><gtr:id>e92b788d7864b365f8d8bb27f411e9b7</gtr:id><gtr:otherNames>Gass J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>BD1B31AB422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1E4DA1-6C2E-46C5-B51A-D5681B65B008</gtr:id><gtr:title>An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d26a3febd09809a570547ffa12ae5ea"><gtr:id>5d26a3febd09809a570547ffa12ae5ea</gtr:id><gtr:otherNames>de Silva R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>2A029FA0089</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400356</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>